Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02872753
Other study ID # ACP-MEN
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date July 11, 2017
Est. completion date January 31, 2023

Study information

Verified date September 2022
Source Istituto Ortopedico Rizzoli
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the present double blind controlled study is to evaluate the effects in terms of pain control and functional recovery provided by a single intra-operative injection of ACP performed at the end of arthroscopic partial meniscectomy. Patients included in this trial will be randomized in two treatment groups: the first one will receive a single injection of 3-5 cc of ACP (using a dedicated centrifuge) at the end of the arthroscopic meniscectomy, whereas the second group will be treated by surgery alone. In order to ensure the double blinding of the trial all the patients enrolled will undergo blood harvesting before anesthesia, and acp will be produced just for the patients included in ACP group. All patients will be evaluated basally, and then at 15, 30, 60, and 180 days after surgery by the following evaluation tools: IKDC (International Knee Documentation Committee) subjective, VAS (Visual Analogue Score) for pain, EQ-VAS for general Health Status, KOOS (Knee Injury and Osteoarthritis Outcome Score) and Tegner score. Furthermore, during the basal evaluation and at each follow-up visit up to 2 months, active and passive Range of Motion (ROM) of both the operated and contralateral knee were documented; also in addition, the trans-patellar circumference of both knees was registered to assess the trend of knee swelling over time. Drugs assumption during the follow-up period will be recorded for each patient. All eventual adverse events occurred during the follow-up period will be registered.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date January 31, 2023
Est. primary completion date August 11, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - chronic symptomatic meniscal tears requiring partial resection; - healthy contra-lateral knee (i.e. no pain or functional limitation in the contra-lateral joint); Exclusion Criteria: - meniscal lesions requiring suture; - previous surgery on the index knee; - other concurrent articular lesion requiring surgical treatment (e.g.: cartilage or ligament injuries); - history of knee infectious arthritis; - concurrent rheumatic, metabolic or severe systemic disease; - Body Mass Index (BMI) > 30; - known hypersensibility or allergy to/towards HA ; - alcohol or other substances abuse/excess.

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
ACP
Autologous Conditioned Plasma will be obtained directly in the operatory room from the peripheral venous blood of the patient, and injected intra-articularly at the end of arthroscopic meniscectomy
Other:
Standard Meniscectomy
Patients will receive standard arthroscopic meniscectomy

Locations

Country Name City State
Italy Rizzoli Orthopaedic Institute Bologna

Sponsors (1)

Lead Sponsor Collaborator
Istituto Ortopedico Rizzoli

Country where clinical trial is conducted

Italy, 

References & Publications (11)

Abrams GD, Frank RM, Gupta AK, Harris JD, McCormick FM, Cole BJ. Trends in meniscus repair and meniscectomy in the United States, 2005-2011. Am J Sports Med. 2013 Oct;41(10):2333-9. doi: 10.1177/0363546513495641. Epub 2013 Jul 17. — View Citation

Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013 Dec;9(12):721-30. doi: 10.1038/nrrheum.2013.141. Epub 2013 Oct 1. — View Citation

Blanke F, Vavken P, Haenle M, von Wehren L, Pagenstert G, Majewski M. Percutaneous injections of Platelet rich plasma for treatment of intrasubstance meniscal lesions. Muscles Ligaments Tendons J. 2015 Oct 20;5(3):162-6. doi: 10.11138/mltj/2015.5.3.162. eCollection 2015 Jul-Sep. — View Citation

Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012 Mar;28(3):429-39. doi: 10.1016/j.arthro.2011.10.018. Epub 2012 Jan 28. — View Citation

Filardo G, Di Matteo B, Di Martino A, Merli ML, Cenacchi A, Fornasari P, Marcacci M, Kon E. Platelet-Rich Plasma Intra-articular Knee Injections Show No Superiority Versus Viscosupplementation: A Randomized Controlled Trial. Am J Sports Med. 2015 Jul;43(7):1575-82. doi: 10.1177/0363546515582027. Epub 2015 May 7. — View Citation

Filardo G, Kon E, Roffi A, Di Matteo B, Merli ML, Marcacci M. Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. Knee Surg Sports Traumatol Arthrosc. 2015 Sep;23(9):2459-74. doi: 10.1007/s00167-013-2743-1. Epub 2013 Nov 26. — View Citation

Griffin JW, Hadeed MM, Werner BC, Diduch DR, Carson EW, Miller MD. Platelet-rich plasma in meniscal repair: does augmentation improve surgical outcomes? Clin Orthop Relat Res. 2015 May;473(5):1665-72. doi: 10.1007/s11999-015-4170-8. Epub 2015 Feb 6. — View Citation

Heard BJ, Barton KI, Chung M, Achari Y, Shrive NG, Frank CB, Hart DA. Single intra-articular dexamethasone injection immediately post-surgery in a rabbit model mitigates early inflammatory responses and post-traumatic osteoarthritis-like alterations. J Orthop Res. 2015 Dec;33(12):1826-34. doi: 10.1002/jor.22972. Epub 2015 Jul 7. — View Citation

Lee HR, Shon OJ, Park SI, Kim HJ, Kim S, Ahn MW, Do SH. Platelet-Rich Plasma Increases the Levels of Catabolic Molecules and Cellular Dedifferentiation in the Meniscus of a Rabbit Model. Int J Mol Sci. 2016 Jan 16;17(1):120. doi: 10.3390/ijms17010120. — View Citation

Pujol N, Salle De Chou E, Boisrenoult P, Beaufils P. Platelet-rich plasma for open meniscal repair in young patients: any benefit? Knee Surg Sports Traumatol Arthrosc. 2015 Jan;23(1):51-8. doi: 10.1007/s00167-014-3417-3. Epub 2014 Nov 7. — View Citation

Thein R, Haviv B, Kidron A, Bronak S. Intra-articular injection of hyaluronic acid following arthroscopic partial meniscectomy of the knee. Orthopedics. 2010 Oct 11;33(10):724. doi: 10.3928/01477447-20100826-11. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Change in IKDC (International Knee Documentation Committee) score over the various follow-up times basal, 15,30,60,180 days
Primary Change in VAS( Visual Analogue score) for pain over the various follow-up times basal, 15,30,60,180 days
Secondary Change in KOOS (Knee Injury and Osteoarthritis Outcome Score) over the various follow-up times basal, 15,30,60,180 days
Secondary Change in Tegner Score over the various follow-up times basal, 30,60,180 days
Secondary Change in transpatellar circumference over time basal, 15,30,60,180 days
Secondary Change in active and passive ROM basal, 15,30,60,180 days
Secondary Adverse events report 15 days after surgery
Secondary Adverse events report 30 days after surgery
Secondary Adverse events report 60 days after surgery
Secondary Adverse events report 180 days after surgery
Secondary Change in VAS for general health status basal, 30,60,180 days
See also
  Status Clinical Trial Phase
Completed NCT01879852 - Muscle Weakness and Post-traumatic Knee OA N/A
Terminated NCT03696836 - AIR (Artificial Implant for Medial Meniscus Replacement) Study N/A
Completed NCT04644640 - Telerehabilitation Following Meniscectomy N/A
Recruiting NCT04972331 - Degenerative Meniscus Without Osteoarthritis : Arthroscopic Partial Menisectomy Versus Platelet Rich Plasma (APM-PRP) N/A
Completed NCT03350204 - Biomechanical Osteoarthritis Outcomes in Meniscectomy Patients N/A
Completed NCT02181426 - Dose Response of Ketorolac in Knee Arthroscopy N/A
Completed NCT02136901 - The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System) N/A
Completed NCT02108496 - Verifying the Effectiveness of the NUsurface® System N/A
Completed NCT01158677 - Short Term Outcome After Meniscectomy
Enrolling by invitation NCT04717609 - Saphenous Nerve Block for Partial Meniscectomy Phase 3
Completed NCT01571102 - Impact of Physiotherapy on Short-term Outcome After Meniscectomy N/A
Terminated NCT00314457 - Efficacy Study of Continuous Intraarticular Infusion in Patients Undergoing Arthroscopic Knee and Shoulder Operations Phase 4